Avacta Group Plc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avacta Group Plc with three other
companies in this sector in the United Kingdom:
Diurnal Group PLC
(2019
sales of £1.04 million [US$1.38 million]
of which 100%
was Alkindi),
Fusion Antibodies PLC
(£2.18 million [US$2.88 million]
), and
Oxford Biodynamics PLC
(£907,000.00 [US$1.20 million]
).
Sales Analysis.
Avacta Group Plc reported sales of £4.12 million (US$5.44 million)
for the
fiscal
year ending
July of 2019.
This
represents
an
increase of 49.2%
versus 2018, when the company's sales were £2.76 million.
This was the fourth straight year of sales growth at Avacta Group Plc.